Chloroquine Phosphate Intended for Fish: FDA Letter to Stakeholders – Do Not Use as Treatment for COVID-19 in Humans
Go to this Safety Alert at MedWatch
Go to this Safety Alert at MedWatch
Pan American Journal of Public Health: Recently published articles / NEW info on COVID-19 for authors and readers
Clinical trials of drug repositioning for COVID-19 treatment
Sandro Rosa and Wilson Santos
Brief communication l Published March 20 2020 l https://doi.org/10.26633/RP
Pan American Journal of Public Health: Recently published articles / NEW info on COVID-19 for authors and readers
No evidence supports the use of ether and chloroform inhalation for treating COVID-19
Paulo Ricardo Martins-Filho and Victor Santana Santos
Letter to the editor l Published March 24 2020 l https://doi.org/10.26633/RPSP.2020.41
PAHO has developed a searchable database that provides access to technical guidelines, scientific publications, and ongoing research protocols from the Americas and affected countries worldwide regarding the coronavirus disease (COVID-19) pandemic.
Recommendations and guidance from the Pan American Health Organization and the World Health Organization are also included, making it a useful platform of trusted information for decision and policy-making authorities, researchers, health professionals, and individuals.
https://www.fda.gov/media/94402/download
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It is intended for blood services, national health authorities, and others responsible for the provision of blood and blood components and integration of the blood system within the public health system. WHO will continue to update this guidance as new information becomes available.
Please, go to https://apps.who.int/iris/rest/bitstreams/1272656/retrieve
REFERENCE NUMBERS
PAHO’s Regional Program on Bioethics has developed a document that provides ethics guidance for the public health response, health care delivery and research during current COVID-19 pandemic.
Such document is available at: https://www.paho.org/en/documents/ethics-guidance-issues-raised-novel-coronavirus-disease-covid-19-pandemic.
In the virtual seminar to PAHO’s ethics guidance for COVID-19 research was presented the imperatives to conduct rapid ethics review of COVID-19 research protocols and to promote future research through the use of broad consent were discussed. The recording is available at: https://paho.webex.com/recordingservice/sites/paho/recording/718eb53feb6b4ba1abe8529be1b96586
PAHO/WHO has developed a webpage dedicated to inform the population on COVID-19 with reliable and updated information: Click here to access the page.
Additionally, all PAHO technical documentation regarding COVID-19 can be found here
Investigational COVID-19 Convalescent Plasma – Emergency INDs
FDA is facilitating access to COVID-19 convalescent plasma for use in patients with serious or immediately life-threatening COVID-19 infections through the process of single patient emergency Investigational New Drug Applications (eINDs) for Individual patients under 21 CFR 312.310. This process allows the use of an investigational drug for the treatment of an individual patient by a licensed physician upon FDA authorization. This does not include the use of COVID-19 convalescent plasma for the prevention of infection.